BSE Live
Sep 29, 15:20Prev. Close
5425.95
Open Price
5408.00
Bid Price (Qty.)
5404.95 (4)
Offer Price (Qty.)
5413.50 (3)
NSE Live
Sep 29, 15:20Prev. Close
5433.00
Open Price
5400.00
Bid Price (Qty.)
5408.50 (89)
Offer Price (Qty.)
5410.00 (2)
Profit & Loss account of Alkem Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 12,804.62 | 12,439.24 | 11,440.35 | 10,634.19 | 8,728.40 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 12,804.62 | 12,439.24 | 11,440.35 | 10,634.19 | 8,728.40 | |
Total Operating Revenues | 12,964.52 | 12,667.58 | 11,599.26 | 10,634.19 | 8,865.01 | |
Other Income | 493.74 | 310.84 | 216.08 | 162.65 | 233.21 | |
Total Revenue | 13,458.26 | 12,978.42 | 11,815.34 | 10,796.84 | 9,098.22 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 3,440.37 | 3,294.59 | 3,056.92 | 3,226.06 | 2,394.54 | |
Purchase Of Stock-In Trade | 1,514.02 | 1,628.87 | 1,387.55 | 1,489.71 | 1,437.76 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Changes In Inventories Of FGWIP And Stock In Trade | -190.13 | 14.12 | 462.37 | -535.48 | -333.84 | |
Employee Benefit Expenses | 2,453.92 | 2,201.01 | 2,131.35 | 1,962.71 | 1,621.03 | |
Finance Costs | 121.70 | 112.41 | 107.36 | 52.37 | 58.92 | |
Depreciation And Amortisation Expenses | 357.16 | 299.30 | 310.42 | 303.96 | 274.58 | |
Other Expenses | 3,234.19 | 3,283.50 | 2,951.62 | 2,438.27 | 1,803.13 | |
Total Expenses | 10,931.23 | 10,833.80 | 10,407.59 | 8,937.60 | 7,256.12 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 2,527.03 | 2,144.62 | 1,407.75 | 1,859.24 | 1,842.10 | |
Exceptional Items | 0.00 | -121.49 | -102.98 | -14.96 | 0.00 | |
Profit/Loss Before Tax | 2,527.03 | 2,023.13 | 1,304.77 | 1,844.28 | 1,842.10 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 523.60 | 422.28 | 273.90 | 361.98 | 396.53 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | -212.57 | -210.61 | 24.06 | -198.02 | -172.20 | |
Other Direct Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Tax Expenses | 311.03 | 211.67 | 297.96 | 163.96 | 224.33 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 2,216.00 | 1,811.46 | 1,006.81 | 1,680.32 | 1,617.77 | |
Profit/Loss From Continuing Operations | 2,216.00 | 1,811.46 | 1,006.81 | 1,680.32 | 1,617.77 | |
Profit/Loss For The Period | 2,216.00 | 1,811.46 | 1,006.81 | 1,680.32 | 1,617.77 | |
Minority Interest | -49.90 | -15.69 | -22.64 | -34.70 | -32.75 | |
Consolidated Profit/Loss After MI And Associates | 2,165.48 | 1,795.77 | 984.17 | 1,645.62 | 1,585.02 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 181.00 | 150.00 | 82.00 | 138.00 | 133.00 | |
Diluted EPS (Rs.) | 181.00 | 150.00 | 82.00 | 138.00 | 133.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 502.17 | 538.04 | 526.09 | 0.00 | 334.78 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
29.09.2025
23.09.2025
19.09.2025
10.09.2025
Alkem Lab Standalone June 2025 Net Sales at Rs 2,372.17 crore, down 5.12% Y-o-Y
10.09.2025
Alkem Lab Standalone June 2025 Net Sales at Rs 2,372.17 crore, down 5.12% Y-o-Y
12.08.2025
Q1 Results impact: Alkem Labs, PN Gadgil shares rally up to 10% on strong earnings, Granules up 4%
12.06.2025
Alkem Lab Standalone March 2025 Net Sales at Rs 2,044.94 crore, down 13.55% Y-o-Y
05.06.2025
Alkem Lab Consolidated March 2025 Net Sales at Rs 3,143.75 crore, up 7.08% Y-o-Y
12.07.2023
Alkem Laboratories Q1 PAT seen up 135.1% YoY to Rs 299.7 cr: Nirmal Bang
17.10.2018
Alkem Labs Q2 PAT may dip 30.2% YoY to Rs. 220 cr: HDFC Securities
20.04.2018
Alkem Labs Q4 PAT may dip 1.5% YoY to Rs. 130 cr: HDFC Securities
12.04.2018
Pharma Q4 earnings preview: Tough quarter; US pricing pressure, domestic sales recovery hold key